Cover Image
市場調查報告書

高磷酸鹽血症:全球臨床實驗趨勢

Hyperphosphatemia Global Clinical Trials Review, H2, 2015

出版商 GlobalData 商品編碼 233632
出版日期 內容資訊 英文 110 Pages
訂單完成後即時交付
價格
Back to Top
高磷酸鹽血症:全球臨床實驗趨勢 Hyperphosphatemia Global Clinical Trials Review, H2, 2015
出版日期: 2015年07月15日 內容資訊: 英文 110 Pages
簡介

本報告提供高磷酸鹽血症臨床實驗相關之最新趨勢分析,提供您各地區的臨床實驗數量,臨床實驗的各階段進展,受驗對象採用狀況,有潛力的贊助商,各企業和研究機關的研究進展,有潛力的藥劑比較等資訊。

簡介

  • 高磷酸鹽血症
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要5國的臨床實驗數量
    • 歐洲主要5國的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲主要國家的臨床實驗數量
    • 中南美主要國家的臨床實驗數量

G7各國臨床實驗數量:營養障礙治療藥臨床實驗上高磷酸鹽血症的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:營養障礙治療藥臨床實驗上高磷酸鹽血症的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標的達成情形

未完成的臨床實驗數量

一定期間所採用的受驗對象

贊助商類別的臨床實驗數量

有潛力的贊助商

高磷酸鹽血症治療藥臨床實驗主要的參與企業

有潛力的藥劑

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Bayer AG
    • Astellas Pharma Inc.
    • Shire Plc
    • Sanofi
    • 三菱化學控股
    • AstraZeneca Plc
    • Galenica Ltd.
    • Ardelyx, Inc.
    • Amgen Inc.
  • 有代表性的研究機關·醫院臨床實驗概要
    • Washington University School of Medicine
    • All India Institute of Medical Sciences
    • Arak University of Medical Sciences
    • Brigham and Women's Hospital
    • CKD-MBD Clinical Study Group
    • COLC Study Research group
    • Denver Nephrology
    • Islamic Azad University of Tabriz
    • 順天堂大學
    • 順天堂大學醫學系

5個有代表性的臨床實驗簡介

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC2770CTIDB

GlobalData's clinical trial report, "Hyperphosphatemia Global Clinical Trials Review, H2, 2015" provides an overview of Hyperphosphatemia clinical trials scenario. This report provides top line data relating to the clinical trials on Hyperphosphatemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Hyperphosphatemia
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Hyperphosphatemia to Nutritional Disorders Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Hyperphosphatemia to Nutritional Disorders Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Hyperphosphatemia
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Hyperphosphatemia Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Bayer AG
      • Clinical Trial Overview of Bayer AG
      • Astellas Pharma Inc.
      • Clinical Trial Overview of Astellas Pharma Inc.
      • Shire Plc
      • Clinical Trial Overview of Shire Plc
      • Sanofi
      • Clinical Trial Overview of Sanofi
      • Mitsubishi Chemical Holdings Corporation
      • Clinical Trial Overview of Mitsubishi Chemical Holdings Corporation
      • AstraZeneca Plc
      • Clinical Trial Overview of AstraZeneca Plc
      • Galenica Ltd.
      • Clinical Trial Overview of Galenica Ltd.
      • Ardelyx, Inc.
      • Clinical Trial Overview of Ardelyx, Inc.
      • Amgen Inc.
      • Clinical Trial Overview of Amgen Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • Washington University School of Medicine
      • Clinical Trial Overview of Washington University School of Medicine
      • All India Institute of Medical Sciences
      • Clinical Trial Overview of All India Institute of Medical Sciences
      • Arak University of Medical Sciences
      • Clinical Trial Overview of Arak University of Medical Sciences
      • Brigham and Women's Hospital
      • Clinical Trial Overview of Brigham and Women's Hospital
      • CKD-MBD Clinical Study Group
      • Clinical Trial Overview of CKD-MBD Clinical Study Group
      • COLC Study Research group
      • Clinical Trial Overview of COLC Study Research group
      • Denver Nephrology
      • Clinical Trial Overview of Denver Nephrology
      • Islamic Azad University of Tabriz
      • Clinical Trial Overview of Islamic Azad University of Tabriz
      • Juntendo University
      • Clinical Trial Overview of Juntendo University
      • Juntendo University School of Medicine
      • Clinical Trial Overview of Juntendo University School of Medicine
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Hyperphosphatemia Therapeutics, Global, Clinical Trials by Region, 2015*
  • Hyperphosphatemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Hyperphosphatemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Hyperphosphatemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015*
  • Hyperphosphatemia Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Hyperphosphatemia Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Hyperphosphatemia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015*
  • Hyperphosphatemia Therapeutics Clinical Trials, Central and South America, Top Countries, 2015*
  • Proportion of Hyperphosphatemia to Nutritional Disorders Clinical Trials, G7 Countries (%), 2015*
  • Hyperphosphatemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Hyperphosphatemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Hyperphosphatemia to Nutritional Disorders Clinical Trials, E7 Countries (%), 2015*
  • Hyperphosphatemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Hyperphosphatemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Hyperphosphatemia Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Hyperphosphatemia Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Hyperphosphatemia Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Hyperphosphatemia Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Hyperphosphatemia Therapeutics, Global, Withdrawn Clinical Trials, 2015*
  • Hyperphosphatemia Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Hyperphosphatemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Hyperphosphatemia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Hyperphosphatemia Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Hyperphosphatemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Hyperphosphatemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Hyperphosphatemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015*
  • Hyperphosphatemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2015*
  • Hyperphosphatemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Shire Plc, 2015*
  • Hyperphosphatemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2015*
  • Hyperphosphatemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Mitsubishi Chemical Holdings Corporation, 2015*
  • Hyperphosphatemia Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca Plc, 2015*
  • Hyperphosphatemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Galenica Ltd., 2015*
  • Hyperphosphatemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Ardelyx, Inc., 2015*
  • Hyperphosphatemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2015*
  • Hyperphosphatemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2015*
  • Hyperphosphatemia Therapeutics Clinical Trials Market, Global, Clinical Trials by All India Institute of Medical Sciences, 2015*
  • Hyperphosphatemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Arak University of Medical Sciences, 2015*
  • Hyperphosphatemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Brigham and Women's Hospital, 2015*
  • Hyperphosphatemia Therapeutics Clinical Trials Market, Global, Clinical Trials by CKD-MBD Clinical Study Group, 2015*
  • Hyperphosphatemia Therapeutics Clinical Trials Market, Global, Clinical Trials by COLC Study Research group, 2015*
  • Hyperphosphatemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Denver Nephrology, 2015*
  • Hyperphosphatemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Islamic Azad University of Tabriz, 2015*
  • Hyperphosphatemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Juntendo University, 2015*
  • Hyperphosphatemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Juntendo University School of Medicine, 2015*

List of Figures

  • Hyperphosphatemia Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Hyperphosphatemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Hyperphosphatemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Hyperphosphatemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015*
  • Hyperphosphatemia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Hyperphosphatemia Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Hyperphosphatemia Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015*
  • Hyperphosphatemia Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015*
  • Proportion of Hyperphosphatemia to Nutritional Disorders Clinical Trials, G7 Countries (%), 2015*
  • Hyperphosphatemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Hyperphosphatemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Hyperphosphatemia to Nutritional Disorders Clinical Trials, E7 Countries (%), 2015*
  • Hyperphosphatemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Hyperphosphatemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Hyperphosphatemia Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Hyperphosphatemia Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Hyperphosphatemia Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Hyperphosphatemia Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Hyperphosphatemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Hyperphosphatemia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Hyperphosphatemia Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Hyperphosphatemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Hyperphosphatemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top